Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Hofseth Biocare ASA    HBC   NO0010598683

HOFSETH BIOCARE ASA (HBC)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 04/24 04:25:10 pm
1.76 NOK   -6.88%
04/06HOFSETH BIOCARE : Call for Annual General Meeting
AQ
03/16HOFSETH BIOCARE : HBC Annual Report 2017
AQ
02/15HOFSETH BIOCARE : HBC Fourth Quarter 2017 Financial Report
AQ
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Hofseth Biocare ASA : quaterly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 03:15pm CEST

The company will report its earnings for Q3 2017 on 11/15/2017. Generally, the company reports earnings worse than estimates. In recent months, the analysts from Thomson Reuters consensus have revised their EPS estimates downward.


© 4-traders.com 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HOFSETH BIOCARE ASA
04/06HOFSETH BIOCARE ASA : Call for Annual General Meeting
AQ
03/16HOFSETH BIOCARE ASA : HBC Annual Report 2017
AQ
02/15HOFSETH BIOCARE ASA : HBC Fourth Quarter 2017 Financial Report
AQ
01/11HOFSETH BIOCARE ASA : Financial update
AQ
2017HOFSETH BIOCARE ASA : HBC Third Quarter 2017 Financial Report
AQ
2017HOFSETH BIOCARE ASA : quaterly earnings release
2017HOFSETH BIOCARE ASA : HBC enters into a new NOK 35m financing agreement
AQ
2017HOFSETH BIOCARE ASA : Mandatory notification of trade, primary insider in hofset..
AQ
2017HOFSETH BIOCARE ASA : Financial Update
AQ
2017HOFSETH BIOCARE ASA : Changes in board of directors - ola holen to function as n..
AQ
More news
Chart HOFSETH BIOCARE ASA
Duration : Period :
Hofseth Biocare ASA Technical Analysis Chart | HBC | NO0010598683 | 4-Traders
Technical analysis trends HOFSETH BIOCARE ASA
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Managers
NameTitle
Roger Hofseth Chief Executive Officer
Ola Holen Chairman
Karl Inge Slotsvik Chief Operating Officer
Jon Olav Ødegård Chief Financial Officer
Bomi Patel Framroze Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
HOFSETH BIOCARE ASA8.00%54
NESTLÉ-10.26%240 087
THE KRAFT HEINZ COMPANY-25.82%70 959
MONDELEZ INTERNATIONAL-5.72%59 492
DANONE-5.76%54 396
ASSOCIATED BRITISH FOODS-7.34%29 046